Johnson & Johnson

The first-quarter earnings reporting season kicks into high gear this week. Highlights will include the latest results from two technology giants. Wall Street analysts are looking for earnings growth from both of them. The new earnings season is underway, and among the highlights this week will...

The first-quarter earnings reporting season kicks into high gear this week. Highlights will include the latest results from two beverage giant rivals. Wall Street analysts are looking for earnings declines from both of them. The new earnings season is underway, and among the highlights this week...

Short interest in many leading biotech stocks tumbled in the most recent period. Amgen, Inc. (NASDAQ: AMGN), Biogen Inc (NASDAQ: BIIB) and Celgene Corporation (NASDAQ: CELG) saw sharp drops in their short interest in late October. A few biotech stocks did see a modest bump in the number shares...

Short interest changes in biotech stocks were mixed during the most recent period. Baxalta Inc (NYSE: BXLT) and Juno Therapeutics Inc (NASDAQ: JUNO) saw short interest surges in late September. Short interest in Medivation Inc (NASDAQ: MDVN) plunged during that time. With the ongoing market...

In the second part of a two-part interview with Noble Biomaterials CEO Jeff Keane, the executive discussed the potential ramifications of the use of Noble's X-static anti-microbial and soft-surface conductivity technology in healthcare. Read part one of the interview here. It begins, Keane...

Nuclear talks were set to continue for another day on Monday as the U.S. and the European Union tried to come to an agreement with Iran about the country’s nuclear capabilities. World powers and Iran have set a November 24 deadline to come up with a comprehensive, long-term agreement...

U.S. stocks reversed early morning gains following a fatal shooting of a Canadian soldier in the nation's capital and a subsequent gunfight inside Canada's Parliament. Declining oil prices was also cited as a factor for the poor performance in equities on Wednesday following the release...

Johnson & Johnson (NYSE: JNJ) has developed a vaccine to fight Ebola and will begin testing the drug on humans in January. If the vaccine is deemed safe by health authorities, the company could make 250,000 doses available by May. The vaccine will be the world’s first and is...

U.S. markets ended the day mostly flat after giving up earlier gains. The Dow traded higher by 142 points before ending the day in negative territory. The S&P 500 and Nasdaq indices closed the day almost unchanged. The CBOE Volatility Index fell 7.5 percent to 23.79. Airline stocks traded...

The new earnings crunch is on, and this week brings a good look at state of the big banks, some key technology and Internet players, and others. Expectations are high for the likes of Goldman Sachs Group Inc (NYSE: GS), Google Inc (NASDAQ: GOOGL) and Intel Corporation (NASDAQ: INTC). Modest growth...

U.S. stocks reversed early morning declines and closed the day little changed ahead of Friday's job reports data, which will be released at 8:30 A.M. The number of Americans filing claims for unemployment benefits unexpectedly fell last week by 8,000 according to data released today. Not...

As the 3D space shows signs of becoming less novelty and more mainstream, the idea of acquiring 3D startups does too. Here are five 3D startups, each with a unique niche, along with publicly traded companies that could have reason to be interested in acquiring them – someday. My Mini...

With a vote to determine who will have control of Congress next year just around the corner, Republicans from the House of Representatives voted to allow lawyers to put together a case against U.S. President Barack Obama. The President is being sued for allegedly overstepping his boundaries and...